Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | PIMAVANSERIN | pimavanserin tartrate | CAPSULE;ORAL | 214925-001 | Jan 16, 2024 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Msn | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 209965-001 | Sep 5, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | DEFERASIROX | deferasirox | GRANULE;ORAL | 214650-003 | Apr 20, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 211901-001 | Jul 24, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211134-001 | May 22, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 214827-004 | Jan 27, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 216512-001 | Sep 21, 2023 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |